Although, these studies suggest that both PAXX and XLF perform overlapping but essential functions in NHEJ mediated DNA repair and influence drug resistance in solid tumors, the consequences and clinical implications of their altered expression in cancer patients have never been investigated. The gene discussed is PAXX; the disease is cancer.